DEA’s suspension of McKesson Corporation Retraction

Posted in Latest News on January 19, 2017.

The previous post, regarding the DEA’s suspension of McKesson Corporation’s sales of controlled substances from distribution in Florida, was found to be confusing. This suspension will impact one distribution center in Florida and impacts only the handling of hydromorphone. The Florida Department of Health and Division of Medical Quality Assurance apologizes for any confusion that may have resulted from that message. For specific details about McKesson’s agreement with the DEA, please contact the DEA. For questions about the potential impact of the sanctions in Florida, please contact the DOH’s Medical Quality Assurance.



More Latest News

Questions about Your License Deactivation?
January 15, 2019

Some RN/LPN licenses are being deactivated as part of the ongoing implementation of the Nurse Licensure Compact. Click here for info about this process & why it’s happening. Continue reading


Florida Board of Nursing Elects Officers for 2019
December 12, 2018

Click here to find out more information about the newly elected Board of Nursing leadership officials for 2019. Continue reading